|By Business Wire||
|July 28, 2014 09:01 AM EDT||
Technology company MC10 Inc. and global biopharmaceutical company UCB announced that they have entered into a partnership to develop MC10’s Biostamp™ platform for patient-focused disease management solutions. The collaboration will evaluate the integration of MC10’s novel, conformal sensing platform with UCB’s pharmaceutical products to make a positive difference in the lives of people living with severe neurological disorders.
MC10® develops stretchable, electronic sensing systems that bend, flex, and twist to match the properties of the human body. MC10’s Biostamp™ platform offers a unique, patient-friendly solution for disease monitoring and management. This passive monitoring of patient health data will not only help patients but also doctors to provide more personalized care. Additionally, it could help to accelerate neuroscience clinical research and provide insight into the real world impact of therapies.
“Wearable technology has the power to transform the way healthcare is both received and delivered,” said Ben Schlatka, Co-Founder & Vice President of Corporate Development at MC10. “At MC10, we have recognized that the most exciting applications of our technology emerge through collaborations with industry-leading partners. UCB’s patient-centric approach to medicine was a great fit with MC10’s human-centric approach to wearable technology design. We look forward to working together to build an innovative solution for patients living with severe diseases.”
“At UCB, we are committed to transforming the lives of people living with severe diseases by finding innovative ways to provide patients with solutions to problems that medicines alone cannot address,” said Michael Gold, Vice President, Head of CNS practice, of UCB. “That is why we are pleased and excited to team up with MC10, with the aim to help patients and their families enjoy more normal, everyday lives.”
About MC10 Inc.
MC10 reshapes electronics to make life better. The company takes conventional high-performance electronics, and turns them into body-integrated form factors that stretch, bend and twist seamlessly with our bodies and the natural world. MC10 is headquartered in Cambridge, MA. Visit MC10 online at www.mc10inc.com.
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in approximately 40 countries, the company generated revenue of € 3.4 billion in 2013. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news
Early adopters of IoT viewed it mainly as a different term for machine-to-machine connectivity or M2M. This is understandable since a prerequisite for any IoT solution is the ability to collect and aggregate device data, which is most often presented in a dashboard. The problem is that viewing data in a dashboard requires a human to interpret the results and take manual action, which doesn’t scale to the needs of IoT.
Jul. 23, 2016 11:00 AM EDT Reads: 1,796
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
Jul. 23, 2016 11:00 AM EDT Reads: 431
Cloud analytics is dramatically altering business intelligence. Some businesses will capitalize on these promising new technologies and gain key insights that’ll help them gain competitive advantage. And others won’t. Whether you’re a business leader, an IT manager, or an analyst, we want to help you and the people you need to influence with a free copy of “Cloud Analytics for Dummies,” the essential guide to this explosive new space for business intelligence.
Jul. 23, 2016 11:00 AM EDT Reads: 436
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, provided tips on how to be successful in large scale machine learning...
Jul. 23, 2016 11:00 AM EDT Reads: 1,116
Jul. 23, 2016 10:45 AM EDT Reads: 1,948
Jul. 23, 2016 10:00 AM EDT Reads: 1,887
Jul. 23, 2016 10:00 AM EDT Reads: 1,026
Jul. 23, 2016 09:45 AM EDT Reads: 948
Jul. 23, 2016 09:45 AM EDT Reads: 1,720
Jul. 23, 2016 09:15 AM EDT Reads: 1,000
Jul. 23, 2016 09:00 AM EDT Reads: 809
Jul. 23, 2016 09:00 AM EDT Reads: 1,912
Jul. 23, 2016 08:30 AM EDT Reads: 649
Jul. 23, 2016 08:15 AM EDT Reads: 1,432
When building large, cloud-based applications that operate at a high scale, it’s important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. “Fly two mistakes high” is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Lee...
Jul. 23, 2016 08:00 AM EDT Reads: 1,234